Abstract
Dyspnea and exercise limitation are the dominant symptoms of patients with chronic obstructive pulmonary disease (COPD) and progress relentlessly as the disease advances. Effective management of these disabling symptoms awaits a better understanding of their underlying physiology. Recent research has identified a number of physiological mechanisms that can be targeted for therapeutic manipulation. Thus, interventions that improve dynamic ventilatory mechanics during exercise or reduce ventilatory demand (relative to capacity) will consistently improve exertional symptoms and physical performance even in patients with severe COPD. In this review we will attempt to provide a physiological construct to explain how modern bronchodilator therapy effectively relieves dyspnea and improves exercise endurance in COPD. We will then discuss new advances in our understanding of how oxygen enrichment of the inspired air results in impressive improvements of exertional symptoms and exercise performance even in patients without significant activityinduced arterial oxygen desaturation. Finally, we will demonstrate how combining therapies that improve airflow dynamics with those that alter the central neural drive to breathe have additive and clinically meaningful benefits in patients with advanced COPD.
Keywords: COPD, spirometry, dynamic hyperinflation, bronchodilators, oxygen, heliox, respiratory mechanics, dyspnea, exercise capacity
Current Respiratory Medicine Reviews
Title: Pharmacological Treatment in Chronic Obstructive Pulmonary Disease
Volume: 4 Issue: 4
Author(s): Pierantonio Laveneziana, Dennis Jensen, Katherine Webb and Denis E. O'Donnell
Affiliation:
Keywords: COPD, spirometry, dynamic hyperinflation, bronchodilators, oxygen, heliox, respiratory mechanics, dyspnea, exercise capacity
Abstract: Dyspnea and exercise limitation are the dominant symptoms of patients with chronic obstructive pulmonary disease (COPD) and progress relentlessly as the disease advances. Effective management of these disabling symptoms awaits a better understanding of their underlying physiology. Recent research has identified a number of physiological mechanisms that can be targeted for therapeutic manipulation. Thus, interventions that improve dynamic ventilatory mechanics during exercise or reduce ventilatory demand (relative to capacity) will consistently improve exertional symptoms and physical performance even in patients with severe COPD. In this review we will attempt to provide a physiological construct to explain how modern bronchodilator therapy effectively relieves dyspnea and improves exercise endurance in COPD. We will then discuss new advances in our understanding of how oxygen enrichment of the inspired air results in impressive improvements of exertional symptoms and exercise performance even in patients without significant activityinduced arterial oxygen desaturation. Finally, we will demonstrate how combining therapies that improve airflow dynamics with those that alter the central neural drive to breathe have additive and clinically meaningful benefits in patients with advanced COPD.
Export Options
About this article
Cite this article as:
Laveneziana Pierantonio, Jensen Dennis, Webb Katherine and O'Donnell E. Denis, Pharmacological Treatment in Chronic Obstructive Pulmonary Disease, Current Respiratory Medicine Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157339808786263833
DOI https://dx.doi.org/10.2174/157339808786263833 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Mechanisms of Action of Gas1 and its Possible Therapeutic Applications
Current Signal Transduction Therapy Exercise and Postprandial Glycemic Control in Type 2 Diabetes
Current Diabetes Reviews Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment
Current Pharmaceutical Design Adipose Tissue Oxygenation in Obesity: A Matter of Cardiovascular Risk?
Current Pharmaceutical Design Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular Remodeling
Current Pharmaceutical Design Aldosterone and Mineralocorticoid Receptor Antagonists on Pulmonary Hypertension and Right Ventricular Failure: A Review
Current Pharmaceutical Design NADPH Oxidases in the Heart
Current Cardiology Reviews Therapeutic Use of Vitamin D and its Analogues in Autoimmunity
Recent Patents on Inflammation & Allergy Drug Discovery From Rapid to Delayed and Remote Postconditioning: The Evolving Concept of Ischemic Postconditioning in Brain Ischemia
Current Drug Targets Veno-Arterial Extracorporeal Membrane Oxygenation in the Adult: A Bridge to the State of the Art
Current Cardiology Reviews Renal Artery Stenting: Efficacy and Complications
Current Hypertension Reviews Liverworts-Potential Source of Medicinal Compounds
Current Pharmaceutical Design Myocardial Regeneration: What is the Best Approach?
Current Cardiology Reviews Immune Mechanism, Aging, Season and Diseases: Modulatory Role of Melatonin
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Discovery of a Novel Anti-Cancer Agent Targeting Both Topoisomerase I & II as Well as Telomerase Activities in Human Lung Adenocarcinoma A549 Cells In Vitro and In Vivo: Cinnamomum verum Component Cuminaldehyde
Current Cancer Drug Targets Sleep Apnea and Coronary Heart Disease: From Dusk Till Dawn and Further
Current Respiratory Medicine Reviews Impact of Cellular Senescence in Aging and Cancer
Current Pharmaceutical Design Gene Therapy in Cardiovascular Diseases
Current Gene Therapy The Role of the Osteoprotegerin/RANKL/RANK System in Diabetic Vascular Disease
Current Medicinal Chemistry Small Molecules as Anti-TNF Drugs
Current Medicinal Chemistry